Skip to main content
See every side of every news story
Published loading...Updated

Wegovy in Children: Semaglutide Helps Under 12-Year-Olds – Fear Discarded

In a phase 3 study, children with severe obesity were administered semaglutide without apparent developmental disorders.

11 Articles

Berliner MorgenpostBerliner Morgenpost
+9 Reposted by 9 other sources
Lean Right

In a phase 3 study, children with severe obesity were administered semaglutide without apparent developmental disorders.

·Berlin, Germany
Read Full Article

<p>Joana Menezes Nunes, an endocrinologist, was on CNN Saturday to talk about Wegovy, a medicine that is already being tested in minors.</p>

·Portugal
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

IOL Portugal broke the news in Portugal on Saturday, September 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal